Why pharma and all stakeholders in the healthcare ecosystem should undertake a fundamental shift in how evidence to support ...

The disease doesn’t have any FDA approved treatments, leaving families desperate for FDA to approve the treatment.

The collaboration will explore RNA-based small molecule drug candidates aimed at neurological conditions where existing ...

The global biotherapeutics company announced that it will seek to streamline operations as part of a broader transformation ...

Whole genome sequencing market is projected to grow significantly, driven by advancements in technology and personalized ...

Recent advancements in COPD treatments are providing patients with potential new first-line treatments. Pharmaceutical ...

Rob Abbott, CEO, ISPOR, highlights that the United States excels in areas like cancer screening and advanced medical ...

Novo Nordisk reduces Ozempic's price to $499/month for self-paying patients, enhancing access to essential diabetes treatment ...

NIH's new strategy emphasizes transparency, prioritizes urgent health needs, and shifts focus to domestic research and ...

Tonmya is the first new fibromyalgia therapy approved in over 15 years, targeting nonrestorative sleep to alleviate core ...

Vanda Pharmaceuticals won a legal battle as a federal court overturned the FDA's rejection of Hetlioz for jet lag disorder, ...

An examination of proactive preparedness and readiness review for future enrollment in the agency’s QMM program—now in the ...